Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 19, 2011 | VP, Technical Operations | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Jan 19, 2011 | VP, Technical Operations | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Jan 19, 2011 | VP, Intellectual Property | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 250 | |
| Jan 19, 2011 | VP, Intellectual Property | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Jan 19, 2011 | VP, Intellectual Property | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Jan 19, 2011 | VP, Intellectual Property | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Jan 19, 2011 | VP, Intellectual Property | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Jan 19, 2011 | VP, Intellectual Property | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 16, 2010 | Ten Percent Owner | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 6,866,244 | |
| May 19, 2010 | VP, Pharmacology & Biology | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 1,708 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.